Search results for " Respiratory symptoms"

showing 3 items of 3 documents

Early management of COPD: Where are we now and where do we go from here? a delphi consensus project

2019

Fabiano Di Marco,1 Piero Balbo,2 Francesco de Blasio,3 Vittorio Cardaci,4 Nunzio Crimi,5 Giuseppe Girbino,6 Girolamo Pelaia,7 Pietro Pirina,8 Pietro Roversi,9 Pierachille Santus,10,11 Nicola Scichilone,12 Alessandro Vatrella,13 Patrizio Pasqualetti,14 Mauro Carone15 1Department of Health Sciences, University of Milan, Respiratory Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy; 2SC Malattie dell’Apparato Respiratorio, AOU Maggiore della Carità, Novara, Italy; 3Respiratory Medicine and Pulmonary Rehabilitation Section, Clinic Center S.p.A. Private Hospital, Department of Medicine and Health Sciences “V Tiberio”, University of Molise, Campobasso, It…

Adrenergic beta-2 Receptor AgonistPulmonary and Respiratory Medicinedrug combinationspractice guidelines as topicConsensuPredictive Value of Testbronchodilator therapy; dyspnea; italy; respiratory symptoms; adrenal cortex hormones; adrenergic beta-2 receptor agonists; adult; bronchodilator agents; consensus; delphi technique; drug combinations; early diagnosis; early medical intervention; evidence-based medicine; female; humans; italy; male; middle aged; muscarinic antagonists; practice guidelines as topic; predictive value of tests; pulmonary disease; chronic obstructive; surveys and questionnaires; treatment outcomeadrenal cortex hormonesSettore MED/10 - Malattie Dell'Apparato RespiratorioInternational Journal of Chronic Obstructive Pulmonary DiseasedyspnoeaAdrenal Cortex HormonePulmonary Disease Chronic ObstructivemaleDrug CombinationEarly Diagnosiitalymiddle agedSurveys and Questionnairehumansmuscarinic antagonistsBronchodilator AgentOriginal Researchearly medical interventionpulmonary diseaselcsh:RC705-779chronic obstructiveHealth Policyadultbronchodilator agentsEnvironmental and Occupational Healthrespiratory symptomsbronchodilator therapylcsh:Diseases of the respiratory systemdyspneaBronchodilator therapy; Dyspnea; Italy; Respiratory symptoms; Pulmonary and Respiratory Medicine; Health Policy; Public Health Environmental and Occupational Healthpredictive value of testsMuscarinic AntagonistfemaleconsensusRespiratory symptomsurveys and questionnairestreatment outcomePublic Healthdelphi techniqueadrenergic beta-2 receptor agonistsevidence-based medicineHumanearly diagnosis
researchProduct

Urban air pollution and emergency room admissions for respiratory symptoms: a case-crossover study in Palermo, Italy

2011

Abstract Background Air pollution from vehicular traffic has been associated with respiratory diseases. In Palermo, the largest metropolitan area in Sicily, urban air pollution is mainly addressed to traffic-related pollution because of lack of industrial settlements, and the presence of a temperate climate that contribute to the limited use of domestic heating plants. This study aimed to investigate the association between traffic-related air pollution and emergency room admissions for acute respiratory symptoms. Methods From January 2004 through December 2007, air pollutant concentrations and emergency room visits were collected for a case-crossover study conducted in Palermo, Sicily. Ris…

PollutionAdultMaleAdolescentmedia_common.quotation_subjectClimateHealth Toxicology and MutagenesisNitrogen DioxideRespiratory Tract DiseasesAir pollutionmedicine.disease_causeSettore MED/42 - Igiene Generale E Applicatalcsh:RC963-969chemistry.chemical_compoundYoung AdultRisk FactorsEnvironmental healthMedicineHumansSulfur DioxideNitrogen dioxideRespiratory systemSicilymedia_commonAgedPollutantAged 80 and overAir PollutantsCarbon MonoxideAir pollutant concentrationsbusiness.industrylcsh:Public aspects of medicineResearchUrban HealthPublic Health Environmental and Occupational Healthlcsh:RA1-1270Odds ratioair pollution case-crossover respiratory symptoms emergency roomParticulatesMiddle AgedLogistic ModelschemistryCase-Control Studieslcsh:Industrial medicine. Industrial hygieneFemaleParticulate MatterSeasonsbusinessEmergency Service HospitalEnvironmental Health
researchProduct

Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave.

2022

SARS-CoV-2 pandemic has contributed to implement telemedicine, allowing clinicians to follow the patient remotely, therefore minimizing the risk of any exposure to positive COVID-19 patients. We summarize the approaches adopted to treat and monitor severe asthmatic patients during the lockdown phase of the pandemic. Our experience supports the strategy that every effort should be made to minimize patient contact with the health-care system, planning a pathway that allows patients to receive appropriate medical care and continue the biological therapies, thus preventing the loss of disease control and acute severe exacerbations.

Pulmonary and Respiratory MedicineCOVID-19 Health-care management Respiratory symptoms Severe asthmasevere asthmamedicine.medical_specialtyTelemedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaSettore MED/10 - Malattie Dell'Apparato RespiratorioPhase (combat)ArticlePandemicmedicineAsthmatic patientHumansPharmacology (medical)Intensive care medicinehealth-care managementPandemicsbusiness.industrySARS-CoV-2Biochemistry (medical)Patient contactrespiratory symptomsCOVID-19AsthmaCommunicable Disease ControlbusinessPulmonary pharmacologytherapeutics
researchProduct